| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GILD - Guild Esports Plc | BUY | 1,218 @ USD 123 | USD 149,814 | The ETF bought 1218 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 123 compared to the previous average buy price of 112.398. This is 9.4% higher than average price of previous purchases of GILD. |
| VRTX - Vertex Pharmaceuticals Inc | BUY | 352 @ USD 421.67 | USD 148,428 | The ETF bought 352 new shares of VRTX (Vertex Pharmaceuticals Inc). The shares were bought for an average price of 421.67 compared to the previous average buy price of 414.896. This is 1.6% higher than average price of previous purchases of VRTX. |
| AMGN - Amgen Inc | BUY | 478 @ USD 296.7 | USD 141,823 | The ETF bought 478 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 296.7 compared to the previous average buy price of 286.546. This is 3.5% higher than average price of previous purchases of AMGN. |
| REGN - Regeneron Pharmaceuticals Inc | BUY | 172 @ USD 628 | USD 108,016 | The ETF bought 172 new shares of REGN (Regeneron Pharmaceuticals Inc). The shares were bought for an average price of 628 compared to the previous average buy price of 625.052. This is 0.5% higher than average price of previous purchases of REGN. |
| ALNY - Alnylam Pharmaceuticals Inc | BUY | 216 @ USD 423.47 | USD 91,470 | The ETF bought 216 new shares of ALNY (Alnylam Pharmaceuticals Inc). The shares were bought for an average price of 423.47 compared to the previous average buy price of 372.61. This is 13.6% higher than average price of previous purchases of ALNY. |
| AZN - AstraZeneca PLC | BUY | 861 @ USD 82.03 | USD 70,628 | The ETF bought 861 new shares of AZN (AstraZeneca PLC). The shares were bought for an average price of 82.03 compared to the previous average buy price of 74.3491. This is 10.3% higher than average price of previous purchases of AZN. |
| INSM - Insmed Inc | BUY | 351 @ USD 182.77 | USD 64,152 | The ETF bought 351 new shares of INSM (Insmed Inc). The shares were bought for an average price of 182.77 compared to the previous average buy price of 117.5. This is 55.5% higher than average price of previous purchases of INSM. |
| ARGX - argenx NV ADR | BUY | 51 @ USD 831.48 | USD 42,405 | The ETF bought 51 new shares of ARGX (argenx NV ADR). The shares were bought for an average price of 831.48 compared to the previous average buy price of 629.717. This is 32.0% higher than average price of previous purchases of ARGX. |
| BIIB - Biogen Inc | BUY | 244 @ USD 149.33 | USD 36,437 | The ETF bought 244 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 149.33 compared to the previous average buy price of 137.307. This is 8.8% higher than average price of previous purchases of BIIB. |
| INCY - Incyte Corporation | BUY | 325 @ USD 102.92 | USD 33,449 | The ETF bought 325 new shares of INCY (Incyte Corporation). The shares were bought for an average price of 102.92 compared to the previous average buy price of 73.0429. This is 40.9% higher than average price of previous purchases of INCY. |
| UTHR - United Therapeutics Corporation | BUY | 75 @ USD 437.33 | USD 32,800 | The ETF bought 75 new shares of UTHR (United Therapeutics Corporation). The shares were bought for an average price of 437.33 compared to the previous average buy price of 338.369. This is 29.2% higher than average price of previous purchases of UTHR. |
| ILMN - Illumina Inc | BUY | 255 @ USD 116.86 | USD 29,799 | The ETF bought 255 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 116.86 compared to the previous average buy price of 96.503. This is 21.1% higher than average price of previous purchases of ILMN. |
| MEDP - Medpace Holdings Inc | BUY | 47 @ USD 594.53 | USD 27,943 | The ETF bought 47 new shares of MEDP (Medpace Holdings Inc). The shares were bought for an average price of 594.53 compared to the previous average buy price of 384.652. This is 54.6% higher than average price of previous purchases of MEDP. |
| RPRX - Royalty Pharma Plc | BUY | 717 @ USD 37.84 | USD 27,131 | The ETF bought 717 new shares of RPRX (Royalty Pharma Plc). The shares were bought for an average price of 37.84 compared to the previous average buy price of 35.4091. This is 6.9% higher than average price of previous purchases of RPRX. |
| NBIX - Neurocrine Biosciences Inc | BUY | 165 @ USD 143.19 | USD 23,626 | The ETF bought 165 new shares of NBIX (Neurocrine Biosciences Inc). The shares were bought for an average price of 143.19 compared to the previous average buy price of 129.224. This is 10.8% higher than average price of previous purchases of NBIX. |
| ROIV - Roivant Sciences Ltd | BUY | 1,133 @ USD 19.87 | USD 22,513 | The ETF bought 1133 new shares of ROIV (Roivant Sciences Ltd). The shares were bought for an average price of 19.87 compared to the previous average buy price of 12.5575. This is 58.2% higher than average price of previous purchases of ROIV. |
| SNY - Sanofi ADR | BUY | 447 @ USD 49.11 | USD 21,952 | The ETF bought 447 new shares of SNY (Sanofi ADR). The shares were bought for an average price of 49.11 compared to the previous average buy price of 49.9862. This is -1.8% lower than average price of previous purchases of SNY. |
| SMMT - Summit Therapeutics PLC | BUY | 1,237 @ USD 17.49 | USD 21,635 | The ETF bought 1237 new shares of SMMT (Summit Therapeutics PLC). The shares were bought for an average price of 17.49 compared to the previous average buy price of 21.6026. This is -19.0% lower than average price of previous purchases of SMMT. |
| ASND - Ascendis Pharma AS | BUY | 101 @ USD 208.24 | USD 21,032 | The ETF bought 101 new shares of ASND (Ascendis Pharma AS). The shares were bought for an average price of 208.24 compared to the previous average buy price of 176.789. This is 17.8% higher than average price of previous purchases of ASND. |
| GH - Guardant Health Inc | BUY | 208 @ USD 98.14 | USD 20,413 | The ETF bought 208 new shares of GH (Guardant Health Inc). The shares were bought for an average price of 98.14 compared to the previous average buy price of 53.4996. This is 83.4% higher than average price of previous purchases of GH. |
| VTRS - Viatris Inc | BUY | 1,943 @ USD 10.49 | USD 20,382 | The ETF bought 1943 new shares of VTRS (Viatris Inc). The shares were bought for an average price of 10.49 compared to the previous average buy price of 9.54506. This is 9.9% higher than average price of previous purchases of VTRS. |
| BBIO - BridgeBio Pharma Inc | BUY | 319 @ USD 61.37 | USD 19,577 | The ETF bought 319 new shares of BBIO (BridgeBio Pharma Inc). The shares were bought for an average price of 61.37 compared to the previous average buy price of 43.9553. This is 39.6% higher than average price of previous purchases of BBIO. |
| IONS - Ionis Pharmaceuticals Inc | BUY | 266 @ USD 72.88 | USD 19,386 | The ETF bought 266 new shares of IONS (Ionis Pharmaceuticals Inc). The shares were bought for an average price of 72.88 compared to the previous average buy price of 47.26. This is 54.2% higher than average price of previous purchases of IONS. |
| RVMD - Revolution Medicines Inc | BUY | 312 @ USD 58.57 | USD 18,274 | The ETF bought 312 new shares of RVMD (Revolution Medicines Inc). The shares were bought for an average price of 58.57 compared to the previous average buy price of 40.735. This is 43.8% higher than average price of previous purchases of RVMD. |
| BNTX - BioNTech SE | BUY | 167 @ USD 104.83 | USD 17,507 | The ETF bought 167 new shares of BNTX (BioNTech SE). The shares were bought for an average price of 104.83 compared to the previous average buy price of 105.308. This is -0.5% lower than average price of previous purchases of BNTX. |
| EXEL - Exelixis Inc | BUY | 447 @ USD 37.9 | USD 16,941 | The ETF bought 447 new shares of EXEL (Exelixis Inc). The shares were bought for an average price of 37.9 compared to the previous average buy price of 40.9211. This is -7.4% lower than average price of previous purchases of EXEL. |
| BMRN - Biomarin Pharmaceutical Inc | BUY | 318 @ USD 52.52 | USD 16,701 | The ETF bought 318 new shares of BMRN (Biomarin Pharmaceutical Inc). The shares were bought for an average price of 52.52 compared to the previous average buy price of 58.4179. This is -10.1% lower than average price of previous purchases of BMRN. |
| MDGL - Madrigal Pharmaceuticals Inc | BUY | 37 @ USD 444.64 | USD 16,452 | The ETF bought 37 new shares of MDGL (Madrigal Pharmaceuticals Inc). The shares were bought for an average price of 444.64 compared to the previous average buy price of 341.416. This is 30.2% higher than average price of previous purchases of MDGL. |
| MRNA - Moderna Inc | BUY | 646 @ USD 23.75 | USD 15,343 | The ETF bought 646 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 23.75 compared to the previous average buy price of 29.4146. This is -19.3% lower than average price of previous purchases of MRNA. |
| RNA - Avidity Biosciences Inc | BUY | 213 @ USD 69.83 | USD 14,874 | The ETF bought 213 new shares of RNA (Avidity Biosciences Inc). The shares were bought for an average price of 69.83 compared to the previous average buy price of 35.8413. This is 94.8% higher than average price of previous purchases of RNA. |
| JAZZ - Jazz Pharmaceuticals PLC | BUY | 101 @ USD 137.82 | USD 13,920 | The ETF bought 101 new shares of JAZZ (Jazz Pharmaceuticals PLC). The shares were bought for an average price of 137.82 compared to the previous average buy price of 121.112. This is 13.8% higher than average price of previous purchases of JAZZ. |
| HALO - Halozyme Therapeutics Inc | BUY | 194 @ USD 68.05 | USD 13,202 | The ETF bought 194 new shares of HALO (Halozyme Therapeutics Inc). The shares were bought for an average price of 68.05 compared to the previous average buy price of 59.2165. This is 14.9% higher than average price of previous purchases of HALO. |
| MRUS - Merus BV | BUY | 126 @ USD 95.04 | USD 11,975 | The ETF bought 126 new shares of MRUS (Merus BV). The shares were bought for an average price of 95.04 compared to the previous average buy price of 62.8736. This is 51.2% higher than average price of previous purchases of MRUS. |
| CYTK - Cytokinetics Inc | BUY | 198 @ USD 59.62 | USD 11,805 | The ETF bought 198 new shares of CYTK (Cytokinetics Inc). The shares were bought for an average price of 59.62 compared to the previous average buy price of 41.9783. This is 42.0% higher than average price of previous purchases of CYTK. |
| RYTM - Rhythm Pharmaceuticals Inc | BUY | 111 @ USD 104.99 | USD 11,654 | The ETF bought 111 new shares of RYTM (Rhythm Pharmaceuticals Inc). The shares were bought for an average price of 104.99 compared to the previous average buy price of 74.6819. This is 40.6% higher than average price of previous purchases of RYTM. |
| AXSM - Axsome Therapeutics Inc | BUY | 83 @ USD 134.93 | USD 11,199 | The ETF bought 83 new shares of AXSM (Axsome Therapeutics Inc). The shares were bought for an average price of 134.93 compared to the previous average buy price of 113.632. This is 18.7% higher than average price of previous purchases of AXSM. |
| NUVL - Nuvalent Inc | BUY | 111 @ USD 91.02 | USD 10,103 | The ETF bought 111 new shares of NUVL (Nuvalent Inc). The shares were bought for an average price of 91.02 compared to the previous average buy price of 81.4946. This is 11.7% higher than average price of previous purchases of NUVL. |
| KRYS - Krystal Biotech Inc | BUY | 48 @ USD 203.26 | USD 9,756 | The ETF bought 48 new shares of KRYS (Krystal Biotech Inc). The shares were bought for an average price of 203.26 compared to the previous average buy price of 159.009. This is 27.8% higher than average price of previous purchases of KRYS. |
| PTCT - PTC Therapeutics Inc | BUY | 132 @ USD 67.72 | USD 8,939 | The ETF bought 132 new shares of PTCT (PTC Therapeutics Inc). The shares were bought for an average price of 67.72 compared to the previous average buy price of 54.1247. This is 25.1% higher than average price of previous purchases of PTCT. |
| PCVX - Vaxcyte Inc | BUY | 216 @ USD 41.35 | USD 8,932 | The ETF bought 216 new shares of PCVX (Vaxcyte Inc). The shares were bought for an average price of 41.35 compared to the previous average buy price of 44.4131. This is -6.9% lower than average price of previous purchases of PCVX. |
| ARWR - Arrowhead Pharmaceuticals Inc | BUY | 230 @ USD 37.85 | USD 8,706 | The ETF bought 230 new shares of ARWR (Arrowhead Pharmaceuticals Inc). The shares were bought for an average price of 37.85 compared to the previous average buy price of 20.6079. This is 83.7% higher than average price of previous purchases of ARWR. |
| CRSP - Crispr Therapeutics AG | BUY | 151 @ USD 56.41 | USD 8,518 | The ETF bought 151 new shares of CRSP (Crispr Therapeutics AG). The shares were bought for an average price of 56.41 compared to the previous average buy price of 52.4668. This is 7.5% higher than average price of previous purchases of CRSP. |
| ALKS - Alkermes Plc | BUY | 275 @ USD 30.39 | USD 8,357 | The ETF bought 275 new shares of ALKS (Alkermes Plc). The shares were bought for an average price of 30.39 compared to the previous average buy price of 30.3896. This is 0.0% higher than average price of previous purchases of ALKS. |
| ACLX - Arcellx Inc | BUY | 92 @ USD 88.18 | USD 8,113 | The ETF bought 92 new shares of ACLX (Arcellx Inc). The shares were bought for an average price of 88.18 compared to the previous average buy price of 71.4398. This is 23.4% higher than average price of previous purchases of ACLX. |
| PTGX - Protagonist Therapeutics Inc | BUY | 104 @ USD 76.5 | USD 7,956 | The ETF bought 104 new shares of PTGX (Protagonist Therapeutics Inc). The shares were bought for an average price of 76.5 compared to the previous average buy price of 55.6365. This is 37.5% higher than average price of previous purchases of PTGX. |
| AKRO - Akero Therapeutics Inc | BUY | 133 @ USD 54.03 | USD 7,186 | The ETF bought 133 new shares of AKRO (Akero Therapeutics Inc). The shares were bought for an average price of 54.03 compared to the previous average buy price of 49.1076. This is 10.0% higher than average price of previous purchases of AKRO. |
| KYMR - Kymera Therapeutics Inc | BUY | 119 @ USD 59.91 | USD 7,129 | The ETF bought 119 new shares of KYMR (Kymera Therapeutics Inc). The shares were bought for an average price of 59.91 compared to the previous average buy price of 46.0086. This is 30.2% higher than average price of previous purchases of KYMR. |
| IMVT - Immunovant Inc | BUY | 293 @ USD 24.19 | USD 7,088 | The ETF bought 293 new shares of IMVT (Immunovant Inc). The shares were bought for an average price of 24.19 compared to the previous average buy price of 17.8386. This is 35.6% higher than average price of previous purchases of IMVT. |
| CRNX - Crinetics Pharmaceuticals Inc | BUY | 157 @ USD 42.51 | USD 6,674 | The ETF bought 157 new shares of CRNX (Crinetics Pharmaceuticals Inc). The shares were bought for an average price of 42.51 compared to the previous average buy price of 34.6228. This is 22.8% higher than average price of previous purchases of CRNX. |
| LGND - Ligand Pharmaceuticals Incorporated | BUY | 33 @ USD 189.45 | USD 6,252 | The ETF bought 33 new shares of LGND (Ligand Pharmaceuticals Incorporated). The shares were bought for an average price of 189.45 compared to the previous average buy price of 130.363. This is 45.3% higher than average price of previous purchases of LGND. |
| ACAD - ACADIA Pharmaceuticals Inc | BUY | 283 @ USD 21.85 | USD 6,184 | The ETF bought 283 new shares of ACAD (ACADIA Pharmaceuticals Inc). The shares were bought for an average price of 21.85 compared to the previous average buy price of 20.782. This is 5.1% higher than average price of previous purchases of ACAD. |
| PRAX - Praxis Precision Medicines Inc | BUY | 35 @ USD 171.75 | USD 6,011 | The ETF bought 35 new shares of PRAX (Praxis Precision Medicines Inc). The shares were bought for an average price of 171.75 compared to the previous average buy price of 58.8904. This is 191.6% higher than average price of previous purchases of PRAX. |
| AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock | BUY | 527 @ USD 11.35 | USD 5,981 | The ETF bought 527 new shares of AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock). The shares were bought for an average price of 11.35 compared to the previous average buy price of 8.70595. This is 30.4% higher than average price of previous purchases of AMRX. |
| MIRM - Mirum Pharmaceuticals Inc | BUY | 84 @ USD 70.97 | USD 5,961 | The ETF bought 84 new shares of MIRM (Mirum Pharmaceuticals Inc). The shares were bought for an average price of 70.97 compared to the previous average buy price of 54.9032. This is 29.3% higher than average price of previous purchases of MIRM. |
| ADMA - ADMA Biologics Inc | BUY | 400 @ USD 14.63 | USD 5,852 | The ETF bought 400 new shares of ADMA (ADMA Biologics Inc). The shares were bought for an average price of 14.63 compared to the previous average buy price of 17.4723. This is -16.3% lower than average price of previous purchases of ADMA. |
| SUPN - Supernus Pharmaceuticals Inc | BUY | 94 @ USD 57 | USD 5,358 | The ETF bought 94 new shares of SUPN (Supernus Pharmaceuticals Inc). The shares were bought for an average price of 57 compared to the previous average buy price of 37.0203. This is 54.0% higher than average price of previous purchases of SUPN. |
| RARE - Ultragenyx | BUY | 162 @ USD 32.46 | USD 5,259 | The ETF bought 162 new shares of RARE (Ultragenyx). The shares were bought for an average price of 32.46 compared to the previous average buy price of 36.4253. This is -10.9% lower than average price of previous purchases of RARE. |
| RARE - WISETFWTMRARETFP | BUY | 162 @ USD 32.46 | USD 5,259 | The ETF bought 162 new shares of RARE (WISETFWTMRARETFP). The shares were bought for an average price of 32.46 compared to the previous average buy price of 36.4253. This is -10.9% lower than average price of previous purchases of RARE. |
| DYN - Dyne Therapeutics Inc | BUY | 238 @ USD 21.52 | USD 5,122 | The ETF bought 238 new shares of DYN (Dyne Therapeutics Inc). The shares were bought for an average price of 21.52 compared to the previous average buy price of 12.6718. This is 69.8% higher than average price of previous purchases of DYN. |
| DYN - DYNAGREEN EN.PR.GR.H YC 1 | BUY | 238 @ USD 21.52 | USD 5,122 | The ETF bought 238 new shares of DYN (DYNAGREEN EN.PR.GR.H YC 1). The shares were bought for an average price of 21.52 compared to the previous average buy price of 12.6718. This is 69.8% higher than average price of previous purchases of DYN. |
| TARS - Tarsus Pharmaceuticals Inc | BUY | 71 @ USD 71.5 | USD 5,077 | The ETF bought 71 new shares of TARS (Tarsus Pharmaceuticals Inc). The shares were bought for an average price of 71.5 compared to the previous average buy price of 48.2502. This is 48.2% higher than average price of previous purchases of TARS. |
| XENE - Xenon Pharmaceuticals Inc | BUY | 129 @ USD 39.09 | USD 5,043 | The ETF bought 129 new shares of XENE (Xenon Pharmaceuticals Inc). The shares were bought for an average price of 39.09 compared to the previous average buy price of 35.3656. This is 10.5% higher than average price of previous purchases of XENE. |
| TVTX - Travere Therapeutics Inc | BUY | 147 @ USD 34.13 | USD 5,017 | The ETF bought 147 new shares of TVTX (Travere Therapeutics Inc). The shares were bought for an average price of 34.13 compared to the previous average buy price of 19.2334. This is 77.5% higher than average price of previous purchases of TVTX. |
| CGON - CG Oncology, Inc. Common stock | BUY | 128 @ USD 39.07 | USD 5,001 | The ETF bought 128 new shares of CGON (CG Oncology, Inc. Common stock). The shares were bought for an average price of 39.07 compared to the previous average buy price of 29.5752. This is 32.1% higher than average price of previous purchases of CGON. |
| IRON - Ironveld Plc | BUY | 58 @ USD 86.06 | USD 4,991 | The ETF bought 58 new shares of IRON (Ironveld Plc). The shares were bought for an average price of 86.06 compared to the previous average buy price of 58.11. This is 48.1% higher than average price of previous purchases of IRON. |
| GRAL - GRAIL, LLC | BUY | 60 @ USD 80.69 | USD 4,841 | The ETF bought 60 new shares of GRAL (GRAIL, LLC). The shares were bought for an average price of 80.69 compared to the previous average buy price of 51.3136. This is 57.2% higher than average price of previous purchases of GRAL. |
| VCYT - Veracyte Inc | BUY | 132 @ USD 36.12 | USD 4,768 | The ETF bought 132 new shares of VCYT (Veracyte Inc). The shares were bought for an average price of 36.12 compared to the previous average buy price of 30.8257. This is 17.2% higher than average price of previous purchases of VCYT. |
| ARQT - Arcutis Biotherapeutics Inc | BUY | 198 @ USD 24.01 | USD 4,754 | The ETF bought 198 new shares of ARQT (Arcutis Biotherapeutics Inc). The shares were bought for an average price of 24.01 compared to the previous average buy price of 15.8926. This is 51.1% higher than average price of previous purchases of ARQT. |
| FOLD - Amicus Therapeutics Inc | BUY | 509 @ USD 8.99 | USD 4,576 | The ETF bought 509 new shares of FOLD (Amicus Therapeutics Inc). The shares were bought for an average price of 8.99 compared to the previous average buy price of 7.28246. This is 23.4% higher than average price of previous purchases of FOLD. |
| SRRK - Scholar Rock Holding Corp | BUY | 161 @ USD 28.05 | USD 4,516 | The ETF bought 161 new shares of SRRK (Scholar Rock Holding Corp). The shares were bought for an average price of 28.05 compared to the previous average buy price of 35.1053. This is -20.1% lower than average price of previous purchases of SRRK. |
| LEGN - Legend Biotech Corp | BUY | 140 @ USD 32.05 | USD 4,487 | The ETF bought 140 new shares of LEGN (Legend Biotech Corp). The shares were bought for an average price of 32.05 compared to the previous average buy price of 34.919. This is -8.2% lower than average price of previous purchases of LEGN. |
| IDYA - Ideaya Biosciences Inc | BUY | 147 @ USD 30.48 | USD 4,481 | The ETF bought 147 new shares of IDYA (Ideaya Biosciences Inc). The shares were bought for an average price of 30.48 compared to the previous average buy price of 23.0599. This is 32.2% higher than average price of previous purchases of IDYA. |
| APLS - Apellis Pharmaceuticals Inc | BUY | 212 @ USD 20.47 | USD 4,340 | The ETF bought 212 new shares of APLS (Apellis Pharmaceuticals Inc). The shares were bought for an average price of 20.47 compared to the previous average buy price of 21.031. This is -2.7% lower than average price of previous purchases of APLS. |
| MLYS - Mineralys Therapeutics, Inc. Common Stock | BUY | 109 @ USD 39.81 | USD 4,339 | The ETF bought 109 new shares of MLYS (Mineralys Therapeutics, Inc. Common Stock). The shares were bought for an average price of 39.81 compared to the previous average buy price of 19.1099. This is 108.3% higher than average price of previous purchases of MLYS. |
| ADPT - Adaptive Biotechnologies Corp | BUY | 251 @ USD 16.92 | USD 4,247 | The ETF bought 251 new shares of ADPT (Adaptive Biotechnologies Corp). The shares were bought for an average price of 16.92 compared to the previous average buy price of 11.7367. This is 44.2% higher than average price of previous purchases of ADPT. |
| APGE - Apogee Therapeutics, Inc. Common Stock | BUY | 76 @ USD 53.9 | USD 4,096 | The ETF bought 76 new shares of APGE (Apogee Therapeutics, Inc. Common Stock). The shares were bought for an average price of 53.9 compared to the previous average buy price of 43.14. This is 24.9% higher than average price of previous purchases of APGE. |
| AGIO - Agios Pharm | BUY | 96 @ USD 40 | USD 3,840 | The ETF bought 96 new shares of AGIO (Agios Pharm). The shares were bought for an average price of 40 compared to the previous average buy price of 35.7678. This is 11.8% higher than average price of previous purchases of AGIO. |
| BEAM - Beam Therapeutics Inc | BUY | 167 @ USD 22.74 | USD 3,798 | The ETF bought 167 new shares of BEAM (Beam Therapeutics Inc). The shares were bought for an average price of 22.74 compared to the previous average buy price of 20.5495. This is 10.7% higher than average price of previous purchases of BEAM. |
| CNTA - Centessa Pharmaceuticals PLC ADR | BUY | 158 @ USD 23.74 | USD 3,751 | The ETF bought 158 new shares of CNTA (Centessa Pharmaceuticals PLC ADR). The shares were bought for an average price of 23.74 compared to the previous average buy price of 16.2701. This is 45.9% higher than average price of previous purchases of CNTA. |
| DNLI - Denali Therapeutics Inc | BUY | 241 @ USD 14.92 | USD 3,596 | The ETF bought 241 new shares of DNLI (Denali Therapeutics Inc). The shares were bought for an average price of 14.92 compared to the previous average buy price of 15.0862. This is -1.1% lower than average price of previous purchases of DNLI. |
| RXRX - Recursion Pharmaceuticals Inc | BUY | 719 @ USD 5 | USD 3,595 | The ETF bought 719 new shares of RXRX (Recursion Pharmaceuticals Inc). The shares were bought for an average price of 5 compared to the previous average buy price of 5.81427. This is -14.0% lower than average price of previous purchases of RXRX. |
| ANIP - ANI Pharmaceuticals Inc | BUY | 36 @ USD 94.48 | USD 3,401 | The ETF bought 36 new shares of ANIP (ANI Pharmaceuticals Inc). The shares were bought for an average price of 94.48 compared to the previous average buy price of 71.2104. This is 32.7% higher than average price of previous purchases of ANIP. |
| GPCR - Structure Therapeutics Inc. American Depositary Shares | BUY | 98 @ USD 34.01 | USD 3,333 | The ETF bought 98 new shares of GPCR (Structure Therapeutics Inc. American Depositary Shares). The shares were bought for an average price of 34.01 compared to the previous average buy price of 22.5853. This is 50.6% higher than average price of previous purchases of GPCR. |
| IBRX - Immunitybio Inc | BUY | 1,586 @ USD 2.08 | USD 3,299 | The ETF bought 1586 new shares of IBRX (Immunitybio Inc). The shares were bought for an average price of 2.08 compared to the previous average buy price of 2.77559. This is -25.1% lower than average price of previous purchases of IBRX. |
| COGT - Cogent Biosciences Inc | BUY | 231 @ USD 14.13 | USD 3,264 | The ETF bought 231 new shares of COGT (Cogent Biosciences Inc). The shares were bought for an average price of 14.13 compared to the previous average buy price of 10.6024. This is 33.3% higher than average price of previous purchases of COGT. |
| OCUL - Ocular Therapeutix Inc | BUY | 288 @ USD 10.9 | USD 3,139 | The ETF bought 288 new shares of OCUL (Ocular Therapeutix Inc). The shares were bought for an average price of 10.9 compared to the previous average buy price of 9.93678. This is 9.7% higher than average price of previous purchases of OCUL. |
| AUPH - Aurinia Pharmaceuticals Inc | BUY | 218 @ USD 14.27 | USD 3,111 | The ETF bought 218 new shares of AUPH (Aurinia Pharmaceuticals Inc). The shares were bought for an average price of 14.27 compared to the previous average buy price of 8.89631. This is 60.4% higher than average price of previous purchases of AUPH. |
| AVDL - Avadel Pharmaceuticals PLC | BUY | 160 @ USD 18.9 | USD 3,024 | The ETF bought 160 new shares of AVDL (Avadel Pharmaceuticals PLC). The shares were bought for an average price of 18.9 compared to the previous average buy price of 10.6406. This is 77.6% higher than average price of previous purchases of AVDL. |
| EWTX - Edgewise Therapeutics Inc | BUY | 174 @ USD 17.325 | USD 3,015 | The ETF bought 174 new shares of EWTX (Edgewise Therapeutics Inc). The shares were bought for an average price of 17.325 compared to the previous average buy price of 15.734. This is 10.1% higher than average price of previous purchases of EWTX. |
| VCEL - Vericel Corp Ord | BUY | 83 @ USD 36.25 | USD 3,009 | The ETF bought 83 new shares of VCEL (Vericel Corp Ord). The shares were bought for an average price of 36.25 compared to the previous average buy price of 40.8192. This is -11.2% lower than average price of previous purchases of VCEL. |
| TWST - Twist Bioscience Corp | BUY | 100 @ USD 30.06 | USD 3,006 | The ETF bought 100 new shares of TWST (Twist Bioscience Corp). The shares were bought for an average price of 30.06 compared to the previous average buy price of 36.5031. This is -17.7% lower than average price of previous purchases of TWST. |
| HRMY - Harmony Biosciences Holdings | BUY | 95 @ USD 30.72 | USD 2,918 | The ETF bought 95 new shares of HRMY (Harmony Biosciences Holdings). The shares were bought for an average price of 30.72 compared to the previous average buy price of 31.8388. This is -3.5% lower than average price of previous purchases of HRMY. |
| KNSA - Kiniksa Pharmaceuticals Ltd | BUY | 73 @ USD 38.54 | USD 2,813 | The ETF bought 73 new shares of KNSA (Kiniksa Pharmaceuticals Ltd). The shares were bought for an average price of 38.54 compared to the previous average buy price of 29.3698. This is 31.2% higher than average price of previous purchases of KNSA. |
| MNKD - MannKind Corp | BUY | 509 @ USD 5.48 | USD 2,789 | The ETF bought 509 new shares of MNKD (MannKind Corp). The shares were bought for an average price of 5.48 compared to the previous average buy price of 4.70034. This is 16.6% higher than average price of previous purchases of MNKD. |
| QURE - Uniqure NV | BUY | 91 @ USD 30.44 | USD 2,770 | The ETF bought 91 new shares of QURE (Uniqure NV). The shares were bought for an average price of 30.44 compared to the previous average buy price of 22.7658. This is 33.7% higher than average price of previous purchases of QURE. |
| XERS - Xeris Pharmaceuticals Inc | BUY | 276 @ USD 9.9 | USD 2,732 | The ETF bought 276 new shares of XERS (Xeris Pharmaceuticals Inc). The shares were bought for an average price of 9.9 compared to the previous average buy price of 5.9987. This is 65.0% higher than average price of previous purchases of XERS. |
| JANX - Janux Therapeutics Inc | BUY | 99 @ USD 27.01 | USD 2,674 | The ETF bought 99 new shares of JANX (Janux Therapeutics Inc). The shares were bought for an average price of 27.01 compared to the previous average buy price of 27.6634. This is -2.4% lower than average price of previous purchases of JANX. |
| VERA - Vera Therapeutics Inc | BUY | 105 @ USD 24.35 | USD 2,557 | The ETF bought 105 new shares of VERA (Vera Therapeutics Inc). The shares were bought for an average price of 24.35 compared to the previous average buy price of 26.7652. This is -9.0% lower than average price of previous purchases of VERA. |
| TXG - 10X Genomics Inc | BUY | 191 @ USD 13.36 | USD 2,552 | The ETF bought 191 new shares of TXG (10X Genomics Inc). The shares were bought for an average price of 13.36 compared to the previous average buy price of 12.0209. This is 11.1% higher than average price of previous purchases of TXG. |
| TXG - Terex Corporation | BUY | 191 @ USD 13.36 | USD 2,552 | The ETF bought 191 new shares of TXG (Terex Corporation). The shares were bought for an average price of 13.36 compared to the previous average buy price of 12.0209. This is 11.1% higher than average price of previous purchases of TXG. |
| ABCL - Abcellera Biologics Inc | BUY | 495 @ USD 4.87 | USD 2,411 | The ETF bought 495 new shares of ABCL (Abcellera Biologics Inc). The shares were bought for an average price of 4.87 compared to the previous average buy price of 3.91623. This is 24.4% higher than average price of previous purchases of ABCL. |
| BCRX - BioCryst Pharmaceuticals Inc | BUY | 348 @ USD 6.76 | USD 2,352 | The ETF bought 348 new shares of BCRX (BioCryst Pharmaceuticals Inc). The shares were bought for an average price of 6.76 compared to the previous average buy price of 8.34427. This is -19.0% lower than average price of previous purchases of BCRX. |
| STOK - Stoke Therapeutics Inc | BUY | 92 @ USD 25.34 | USD 2,331 | The ETF bought 92 new shares of STOK (Stoke Therapeutics Inc). The shares were bought for an average price of 25.34 compared to the previous average buy price of 15.3819. This is 64.7% higher than average price of previous purchases of STOK. |
| ZYME - Zymeworks Inc. Common Stock | BUY | 128 @ USD 18.16 | USD 2,324 | The ETF bought 128 new shares of ZYME (Zymeworks Inc. Common Stock). The shares were bought for an average price of 18.16 compared to the previous average buy price of 14.1552. This is 28.3% higher than average price of previous purchases of ZYME. |
| SYRE - Spyre Therapeutics Inc. | BUY | 99 @ USD 22.98 | USD 2,275 | The ETF bought 99 new shares of SYRE (Spyre Therapeutics Inc.). The shares were bought for an average price of 22.98 compared to the previous average buy price of 17.3114. This is 32.7% higher than average price of previous purchases of SYRE. |
| ARDX - Ardelyx Inc | BUY | 400 @ USD 5.6 | USD 2,240 | The ETF bought 400 new shares of ARDX (Ardelyx Inc). The shares were bought for an average price of 5.6 compared to the previous average buy price of 4.5835. This is 22.2% higher than average price of previous purchases of ARDX. |
| NVCR - Novocure Ltd | BUY | 185 @ USD 12 | USD 2,220 | The ETF bought 185 new shares of NVCR (Novocure Ltd). The shares were bought for an average price of 12 compared to the previous average buy price of 16.8672. This is -28.9% lower than average price of previous purchases of NVCR. |
| NTLA - Intellia Therapeutics Inc | BUY | 180 @ USD 12.2 | USD 2,196 | The ETF bought 180 new shares of NTLA (Intellia Therapeutics Inc). The shares were bought for an average price of 12.2 compared to the previous average buy price of 12.5369. This is -2.7% lower than average price of previous purchases of NTLA. |
| SNDX - Syndax Pharmaceuticals Inc | BUY | 143 @ USD 15.35 | USD 2,195 | The ETF bought 143 new shares of SNDX (Syndax Pharmaceuticals Inc). The shares were bought for an average price of 15.35 compared to the previous average buy price of 11.4892. This is 33.6% higher than average price of previous purchases of SNDX. |
| WVE - Wave Life Sciences Ltd | BUY | 271 @ USD 8.01 | USD 2,171 | The ETF bought 271 new shares of WVE (Wave Life Sciences Ltd). The shares were bought for an average price of 8.01 compared to the previous average buy price of 8.46359. This is -5.4% lower than average price of previous purchases of WVE. |
| IMCR - Immunocore Holdings Ltd | BUY | 68 @ USD 31.91 | USD 2,170 | The ETF bought 68 new shares of IMCR (Immunocore Holdings Ltd). The shares were bought for an average price of 31.91 compared to the previous average buy price of 32.6574. This is -2.3% lower than average price of previous purchases of IMCR. |
| HROW - Harrow Health Inc | BUY | 61 @ USD 35.31 | USD 2,154 | The ETF bought 61 new shares of HROW (Harrow Health Inc). The shares were bought for an average price of 35.31 compared to the previous average buy price of 33.2175. This is 6.3% higher than average price of previous purchases of HROW. |
| ZLAB - Zai Lab Ltd | BUY | 79 @ USD 25.89 | USD 2,045 | The ETF bought 79 new shares of ZLAB (Zai Lab Ltd). The shares were bought for an average price of 25.89 compared to the previous average buy price of 34.2923. This is -24.5% lower than average price of previous purchases of ZLAB. |
| AMLX - Amylyx Pharmaceuticals Inc | BUY | 148 @ USD 13.74 | USD 2,034 | The ETF bought 148 new shares of AMLX (Amylyx Pharmaceuticals Inc). The shares were bought for an average price of 13.74 compared to the previous average buy price of 6.78109. This is 102.6% higher than average price of previous purchases of AMLX. |
| NVAX - Novavax Inc | BUY | 270 @ USD 7.51 | USD 2,028 | The ETF bought 270 new shares of NVAX (Novavax Inc). The shares were bought for an average price of 7.51 compared to the previous average buy price of 7.38242. This is 1.7% higher than average price of previous purchases of NVAX. |
| NVAX - Hana Microelectronics Public Company Limited | BUY | 270 @ USD 7.51 | USD 2,028 | The ETF bought 270 new shares of NVAX (Hana Microelectronics Public Company Limited). The shares were bought for an average price of 7.51 compared to the previous average buy price of 7.38242. This is 1.7% higher than average price of previous purchases of NVAX. |
| GMAB - Genmab AS | BUY | 69 @ USD 28.76 | USD 1,984 | The ETF bought 69 new shares of GMAB (Genmab AS). The shares were bought for an average price of 28.76 compared to the previous average buy price of 23.1937. This is 24.0% higher than average price of previous purchases of GMAB. |
| CVAC - CureVac NV | BUY | 374 @ USD 5.3 | USD 1,982 | The ETF bought 374 new shares of CVAC (CureVac NV). The shares were bought for an average price of 5.3 compared to the previous average buy price of 4.82813. This is 9.8% higher than average price of previous purchases of CVAC. |
| ORIC - Oric Pharmaceuticals Inc | BUY | 161 @ USD 12.3 | USD 1,980 | The ETF bought 161 new shares of ORIC (Oric Pharmaceuticals Inc). The shares were bought for an average price of 12.3 compared to the previous average buy price of 10.4489. This is 17.7% higher than average price of previous purchases of ORIC. |
| RLAY - Relay Therapeutics Inc | BUY | 287 @ USD 6.86 | USD 1,969 | The ETF bought 287 new shares of RLAY (Relay Therapeutics Inc). The shares were bought for an average price of 6.86 compared to the previous average buy price of 4.09041. This is 67.7% higher than average price of previous purchases of RLAY. |
| PGEN - Precigen Inc | BUY | 506 @ USD 3.88 | USD 1,963 | The ETF bought 506 new shares of PGEN (Precigen Inc). The shares were bought for an average price of 3.88 compared to the previous average buy price of 2.20737. This is 75.8% higher than average price of previous purchases of PGEN. |
| DVAX - Dynavax Technologies Corporation | BUY | 195 @ USD 10.05 | USD 1,960 | The ETF bought 195 new shares of DVAX (Dynavax Technologies Corporation). The shares were bought for an average price of 10.05 compared to the previous average buy price of 10.4637. This is -4.0% lower than average price of previous purchases of DVAX. |
| AMPH - Amphastar P | BUY | 77 @ USD 25.26 | USD 1,945 | The ETF bought 77 new shares of AMPH (Amphastar P). The shares were bought for an average price of 25.26 compared to the previous average buy price of 25.4441. This is -0.7% lower than average price of previous purchases of AMPH. |
| TSHA - Taysha Gene Therapies Inc | BUY | 454 @ USD 4.27 | USD 1,939 | The ETF bought 454 new shares of TSHA (Taysha Gene Therapies Inc). The shares were bought for an average price of 4.27 compared to the previous average buy price of 2.83993. This is 50.4% higher than average price of previous purchases of TSHA. |
| INVA - Innoviva Inc | BUY | 104 @ USD 18.15 | USD 1,888 | The ETF bought 104 new shares of INVA (Innoviva Inc). The shares were bought for an average price of 18.15 compared to the previous average buy price of 18.8346. This is -3.6% lower than average price of previous purchases of INVA. |
| GRFS - Grifols SA ADR | BUY | 203 @ USD 9.22 | USD 1,872 | The ETF bought 203 new shares of GRFS (Grifols SA ADR). The shares were bought for an average price of 9.22 compared to the previous average buy price of 9.46975. This is -2.6% lower than average price of previous purchases of GRFS. |
| ELVN - Enliven Therapeutics Inc. | BUY | 98 @ USD 19.01 | USD 1,863 | The ETF bought 98 new shares of ELVN (Enliven Therapeutics Inc.). The shares were bought for an average price of 19.01 compared to the previous average buy price of 20.3892. This is -6.8% lower than average price of previous purchases of ELVN. |
| COLL - Collegium Pharmaceutical Inc | BUY | 52 @ USD 35.76 | USD 1,860 | The ETF bought 52 new shares of COLL (Collegium Pharmaceutical Inc). The shares were bought for an average price of 35.76 compared to the previous average buy price of 31.2957. This is 14.3% higher than average price of previous purchases of COLL. |
| SANA - Sana Biotechnology Inc | BUY | 437 @ USD 4.15 | USD 1,814 | The ETF bought 437 new shares of SANA (Sana Biotechnology Inc). The shares were bought for an average price of 4.15 compared to the previous average buy price of 3.20006. This is 29.7% higher than average price of previous purchases of SANA. |
| PCRX - Pacira BioSciences, Inc. | BUY | 74 @ USD 22.44 | USD 1,661 | The ETF bought 74 new shares of PCRX (Pacira BioSciences, Inc.). The shares were bought for an average price of 22.44 compared to the previous average buy price of 23.8049. This is -5.7% lower than average price of previous purchases of PCRX. |
| NRIX - Nurix Therapeutics Inc | BUY | 134 @ USD 12.26 | USD 1,643 | The ETF bought 134 new shares of NRIX (Nurix Therapeutics Inc). The shares were bought for an average price of 12.26 compared to the previous average buy price of 12.0482. This is 1.8% higher than average price of previous purchases of NRIX. |
| PHAT - Phathom Pharmaceuticals Inc | BUY | 120 @ USD 13.49 | USD 1,619 | The ETF bought 120 new shares of PHAT (Phathom Pharmaceuticals Inc). The shares were bought for an average price of 13.49 compared to the previous average buy price of 8.79787. This is 53.3% higher than average price of previous purchases of PHAT. |
| XNCR - Xencor Inc | BUY | 118 @ USD 13.7 | USD 1,617 | The ETF bought 118 new shares of XNCR (Xencor Inc). The shares were bought for an average price of 13.7 compared to the previous average buy price of 11.0259. This is 24.3% higher than average price of previous purchases of XNCR. |
| ANAB - AnaptysBio Inc | BUY | 46 @ USD 34.74 | USD 1,598 | The ETF bought 46 new shares of ANAB (AnaptysBio Inc). The shares were bought for an average price of 34.74 compared to the previous average buy price of 23.7388. This is 46.3% higher than average price of previous purchases of ANAB. |
| URGN - UroGen Pharma Ltd | BUY | 79 @ USD 19.81 | USD 1,565 | The ETF bought 79 new shares of URGN (UroGen Pharma Ltd). The shares were bought for an average price of 19.81 compared to the previous average buy price of 14.524. This is 36.4% higher than average price of previous purchases of URGN. |
| MNMD - Mind Medicine Inc | BUY | 129 @ USD 12 | USD 1,548 | The ETF bought 129 new shares of MNMD (Mind Medicine Inc). The shares were bought for an average price of 12 compared to the previous average buy price of 8.47188. This is 41.6% higher than average price of previous purchases of MNMD. |
| KURA - Kura Oncology Inc | BUY | 151 @ USD 9.96 | USD 1,504 | The ETF bought 151 new shares of KURA (Kura Oncology Inc). The shares were bought for an average price of 9.96 compared to the previous average buy price of 7.13912. This is 39.5% higher than average price of previous purchases of KURA. |
| TNGX - Tango Therapeutics Inc | BUY | 185 @ USD 8.00999 | USD 1,482 | The ETF bought 185 new shares of TNGX (Tango Therapeutics Inc). The shares were bought for an average price of 8.00999 compared to the previous average buy price of 6.08872. This is 31.6% higher than average price of previous purchases of TNGX. |
| FTRE - Fortrea Holdings Inc. | BUY | 151 @ USD 9.7 | USD 1,465 | The ETF bought 151 new shares of FTRE (Fortrea Holdings Inc.). The shares were bought for an average price of 9.7 compared to the previous average buy price of 6.46477. This is 50.0% higher than average price of previous purchases of FTRE. |
| ABUS - Arbutus Biopharma Corp | BUY | 325 @ USD 4.5 | USD 1,463 | The ETF bought 325 new shares of ABUS (Arbutus Biopharma Corp). The shares were bought for an average price of 4.5 compared to the previous average buy price of 3.59733. This is 25.1% higher than average price of previous purchases of ABUS. |
| EYPT - Eyepoint Pharmaceuticals Inc | BUY | 115 @ USD 12.39 | USD 1,425 | The ETF bought 115 new shares of EYPT (Eyepoint Pharmaceuticals Inc). The shares were bought for an average price of 12.39 compared to the previous average buy price of 8.66511. This is 43.0% higher than average price of previous purchases of EYPT. |
| SPRY - Silverback Therapeutics Inc | BUY | 163 @ USD 8.71 | USD 1,420 | The ETF bought 163 new shares of SPRY (Silverback Therapeutics Inc). The shares were bought for an average price of 8.71 compared to the previous average buy price of 13.9399. This is -37.5% lower than average price of previous purchases of SPRY. |
| PAHC - Phibro Animal Health Corporation | BUY | 33 @ USD 42.11 | USD 1,390 | The ETF bought 33 new shares of PAHC (Phibro Animal Health Corporation). The shares were bought for an average price of 42.11 compared to the previous average buy price of 28.1774. This is 49.4% higher than average price of previous purchases of PAHC. |
| PRME - Prime Medicine, Inc. Common Stock | BUY | 292 @ USD 4.3 | USD 1,256 | The ETF bought 292 new shares of PRME (Prime Medicine, Inc. Common Stock). The shares were bought for an average price of 4.3 compared to the previous average buy price of 4.56553. This is -5.8% lower than average price of previous purchases of PRME. |
| DAWN - Day One Biopharmaceuticals Inc | BUY | 170 @ USD 7.3 | USD 1,241 | The ETF bought 170 new shares of DAWN (Day One Biopharmaceuticals Inc). The shares were bought for an average price of 7.3 compared to the previous average buy price of 7.37138. This is -1.0% lower than average price of previous purchases of DAWN. |
| TBPH - Theravance Biopharma Inc | BUY | 84 @ USD 14.75 | USD 1,239 | The ETF bought 84 new shares of TBPH (Theravance Biopharma Inc). The shares were bought for an average price of 14.75 compared to the previous average buy price of 11.5918. This is 27.2% higher than average price of previous purchases of TBPH. |
| GERN - Geron Corporation | BUY | 1,057 @ USD 1.15 | USD 1,216 | The ETF bought 1057 new shares of GERN (Geron Corporation). The shares were bought for an average price of 1.15 compared to the previous average buy price of 1.51961. This is -24.3% lower than average price of previous purchases of GERN. |
| VIR - Vir Biotechnology Inc | BUY | 230 @ USD 5.25 | USD 1,208 | The ETF bought 230 new shares of VIR (Vir Biotechnology Inc). The shares were bought for an average price of 5.25 compared to the previous average buy price of 5.84471. This is -10.2% lower than average price of previous purchases of VIR. |
| VIR - Vidrala S.A | BUY | 230 @ USD 5.25 | USD 1,208 | The ETF bought 230 new shares of VIR (Vidrala S.A). The shares were bought for an average price of 5.25 compared to the previous average buy price of 5.84471. This is -10.2% lower than average price of previous purchases of VIR. |
| REPL - Replimune Group Inc | BUY | 133 @ USD 8.97 | USD 1,193 | The ETF bought 133 new shares of REPL (Replimune Group Inc). The shares were bought for an average price of 8.97 compared to the previous average buy price of 8.86462. This is 1.2% higher than average price of previous purchases of REPL. |
| SVRA - Savara Inc | BUY | 288 @ USD 4.13 | USD 1,189 | The ETF bought 288 new shares of SVRA (Savara Inc). The shares were bought for an average price of 4.13 compared to the previous average buy price of 2.74368. This is 50.5% higher than average price of previous purchases of SVRA. |
| ERAS - Erasca Inc | BUY | 508 @ USD 2.31 | USD 1,173 | The ETF bought 508 new shares of ERAS (Erasca Inc). The shares were bought for an average price of 2.31 compared to the previous average buy price of 1.6246. This is 42.2% higher than average price of previous purchases of ERAS. |
| MGTX - MeiraGTx Holdings PLC | BUY | 134 @ USD 8.56 | USD 1,147 | The ETF bought 134 new shares of MGTX (MeiraGTx Holdings PLC). The shares were bought for an average price of 8.56 compared to the previous average buy price of 7.18707. This is 19.1% higher than average price of previous purchases of MGTX. |
| ARVN - Arvinas Inc | BUY | 120 @ USD 9.54001 | USD 1,145 | The ETF bought 120 new shares of ARVN (Arvinas Inc). The shares were bought for an average price of 9.54001 compared to the previous average buy price of 8.69221. This is 9.8% higher than average price of previous purchases of ARVN. |
| IOVA - Iovance Biotherapeutics Inc | BUY | 594 @ USD 1.82 | USD 1,081 | The ETF bought 594 new shares of IOVA (Iovance Biotherapeutics Inc). The shares were bought for an average price of 1.82 compared to the previous average buy price of 2.44149. This is -25.5% lower than average price of previous purchases of IOVA. |
| AVXL - Anavex Life Sciences Corp | BUY | 144 @ USD 7.46999 | USD 1,076 | The ETF bought 144 new shares of AVXL (Anavex Life Sciences Corp). The shares were bought for an average price of 7.46999 compared to the previous average buy price of 9.63603. This is -22.5% lower than average price of previous purchases of AVXL. |
| PACB - Pacific Biosciences of California | BUY | 530 @ USD 2 | USD 1,060 | The ETF bought 530 new shares of PACB (Pacific Biosciences of California). The shares were bought for an average price of 2 compared to the previous average buy price of 1.53703. This is 30.1% higher than average price of previous purchases of PACB. |
| KROS - Keros Therapeutics Inc | BUY | 67 @ USD 15.55 | USD 1,042 | The ETF bought 67 new shares of KROS (Keros Therapeutics Inc). The shares were bought for an average price of 15.55 compared to the previous average buy price of 13.6388. This is 14.0% higher than average price of previous purchases of KROS. |
| RGNX - Regenxbio Inc | BUY | 88 @ USD 11.56 | USD 1,017 | The ETF bought 88 new shares of RGNX (Regenxbio Inc). The shares were bought for an average price of 11.56 compared to the previous average buy price of 9.08069. This is 27.3% higher than average price of previous purchases of RGNX. |
| SIGA - SIGA Technologies Inc | BUY | 118 @ USD 8.13999 | USD 961 | The ETF bought 118 new shares of SIGA (SIGA Technologies Inc). The shares were bought for an average price of 8.13999 compared to the previous average buy price of 6.80881. This is 19.6% higher than average price of previous purchases of SIGA. |
| PRTA - Prothena Corporation plc | BUY | 92 @ USD 10.26 | USD 944 | The ETF bought 92 new shares of PRTA (Prothena Corporation plc). The shares were bought for an average price of 10.26 compared to the previous average buy price of 8.93485. This is 14.8% higher than average price of previous purchases of PRTA. |
| OLMA - Olema Pharmaceuticals Inc | BUY | 113 @ USD 8.2 | USD 927 | The ETF bought 113 new shares of OLMA (Olema Pharmaceuticals Inc). The shares were bought for an average price of 8.2 compared to the previous average buy price of 5.45228. This is 50.4% higher than average price of previous purchases of OLMA. |
| FDMT - 4D Molecular Therapeutics Inc | BUY | 84 @ USD 10.75 | USD 903 | The ETF bought 84 new shares of FDMT (4D Molecular Therapeutics Inc). The shares were bought for an average price of 10.75 compared to the previous average buy price of 6.06174. This is 77.3% higher than average price of previous purchases of FDMT. |
| KALV - Kalvista Pharmaceuticals Inc | BUY | 82 @ USD 10.76 | USD 882 | The ETF bought 82 new shares of KALV (Kalvista Pharmaceuticals Inc). The shares were bought for an average price of 10.76 compared to the previous average buy price of 12.3679. This is -13.0% lower than average price of previous purchases of KALV. |
| LXRX - Lexicon Pharmaceuticals Inc | BUY | 637 @ USD 1.33 | USD 847 | The ETF bought 637 new shares of LXRX (Lexicon Pharmaceuticals Inc). The shares were bought for an average price of 1.33 compared to the previous average buy price of 1.03145. This is 28.9% higher than average price of previous purchases of LXRX. |
| HCM - HUTCHMED China Ltd | BUY | 53 @ USD 15.44 | USD 818 | The ETF bought 53 new shares of HCM (HUTCHMED China Ltd). The shares were bought for an average price of 15.44 compared to the previous average buy price of 15.5111. This is -0.5% lower than average price of previous purchases of HCM. |
| HCM - Hitachi Construction Machinery Co. Ltd | BUY | 53 @ USD 15.44 | USD 818 | The ETF bought 53 new shares of HCM (Hitachi Construction Machinery Co. Ltd). The shares were bought for an average price of 15.44 compared to the previous average buy price of 15.5111. This is -0.5% lower than average price of previous purchases of HCM. |
| CGEM - Cullinan Oncology LLC | BUY | 103 @ USD 7.4 | USD 762 | The ETF bought 103 new shares of CGEM (Cullinan Oncology LLC). The shares were bought for an average price of 7.4 compared to the previous average buy price of 7.86821. This is -6.0% lower than average price of previous purchases of CGEM. |
| GLPG - Galapagos NV ADR | BUY | 25 @ USD 30.46 | USD 762 | The ETF bought 25 new shares of GLPG (Galapagos NV ADR). The shares were bought for an average price of 30.46 compared to the previous average buy price of 29.0888. This is 4.7% higher than average price of previous purchases of GLPG. |
| GLPG - Galapagos N.V. | BUY | 25 @ USD 30.46 | USD 762 | The ETF bought 25 new shares of GLPG (Galapagos N.V.). The shares were bought for an average price of 30.46 compared to the previous average buy price of 29.0888. This is 4.7% higher than average price of previous purchases of GLPG. |
| MRVI - Maravai Lifesciences Holdings Inc | BUY | 264 @ USD 2.87 | USD 758 | The ETF bought 264 new shares of MRVI (Maravai Lifesciences Holdings Inc). The shares were bought for an average price of 2.87 compared to the previous average buy price of 2.68851. This is 6.8% higher than average price of previous purchases of MRVI. |
| EOLS - Evolus Inc | BUY | 118 @ USD 6.41 | USD 756 | The ETF bought 118 new shares of EOLS (Evolus Inc). The shares were bought for an average price of 6.41 compared to the previous average buy price of 9.26816. This is -30.8% lower than average price of previous purchases of EOLS. |
| RCKT - Rocket Pharmaceuticals Inc | BUY | 181 @ USD 3.29 | USD 595 | The ETF bought 181 new shares of RCKT (Rocket Pharmaceuticals Inc). The shares were bought for an average price of 3.29 compared to the previous average buy price of 5.17569. This is -36.4% lower than average price of previous purchases of RCKT. |
| ACIU - AC Immune Ltd | BUY | 170 @ USD 3.3 | USD 561 | The ETF bought 170 new shares of ACIU (AC Immune Ltd). The shares were bought for an average price of 3.3 compared to the previous average buy price of 2.35576. This is 40.1% higher than average price of previous purchases of ACIU. |
| BCYC - Bicycle Therapeutics Ltd | BUY | 80 @ USD 6.87 | USD 550 | The ETF bought 80 new shares of BCYC (Bicycle Therapeutics Ltd). The shares were bought for an average price of 6.87 compared to the previous average buy price of 8.61609. This is -20.3% lower than average price of previous purchases of BCYC. |
| ALT - Altitude Group Plc | BUY | 145 @ USD 3.76 | USD 545 | The ETF bought 145 new shares of ALT (Altitude Group Plc). The shares were bought for an average price of 3.76 compared to the previous average buy price of 5.21518. This is -27.9% lower than average price of previous purchases of ALT. |
| AUTL - Autolus Therapeutics Ltd | BUY | 370 @ USD 1.41 | USD 522 | The ETF bought 370 new shares of AUTL (Autolus Therapeutics Ltd). The shares were bought for an average price of 1.41 compared to the previous average buy price of 1.86751. This is -24.5% lower than average price of previous purchases of AUTL. |
| LYEL - Lyell Immunopharma Inc | BUY | 32 @ USD 15.95 | USD 510 | The ETF bought 32 new shares of LYEL (Lyell Immunopharma Inc). The shares were bought for an average price of 15.95 compared to the previous average buy price of 6.2621. This is 154.7% higher than average price of previous purchases of LYEL. |
| IRWD - Ironwood Pharmaceuticals Inc | BUY | 262 @ USD 1.87 | USD 490 | The ETF bought 262 new shares of IRWD (Ironwood Pharmaceuticals Inc). The shares were bought for an average price of 1.87 compared to the previous average buy price of 1.10524. This is 69.2% higher than average price of previous purchases of IRWD. |
| VNDA - Vanda Pharmaceuticals Inc | BUY | 109 @ USD 4.35 | USD 474 | The ETF bought 109 new shares of VNDA (Vanda Pharmaceuticals Inc). The shares were bought for an average price of 4.35 compared to the previous average buy price of 4.86706. This is -10.6% lower than average price of previous purchases of VNDA. |
| TRDA - Entrada Therapeutics Inc | BUY | 70 @ USD 6.62001 | USD 463 | The ETF bought 70 new shares of TRDA (Entrada Therapeutics Inc). The shares were bought for an average price of 6.62001 compared to the previous average buy price of 7.63452. This is -13.3% lower than average price of previous purchases of TRDA. |
| AVIR - Atea Pharmaceuticals Inc | BUY | 144 @ USD 3.21001 | USD 462 | The ETF bought 144 new shares of AVIR (Atea Pharmaceuticals Inc). The shares were bought for an average price of 3.21001 compared to the previous average buy price of 3.34571. This is -4.1% lower than average price of previous purchases of AVIR. |
| EDIT - Editas Medicine Inc | BUY | 164 @ USD 2.78 | USD 456 | The ETF bought 164 new shares of EDIT (Editas Medicine Inc). The shares were bought for an average price of 2.78 compared to the previous average buy price of 2.74627. This is 1.2% higher than average price of previous purchases of EDIT. |
| ARCT - Arcturus Therapeutics Holdings Inc | BUY | 49 @ USD 8.93001 | USD 438 | The ETF bought 49 new shares of ARCT (Arcturus Therapeutics Holdings Inc). The shares were bought for an average price of 8.93001 compared to the previous average buy price of 14.7974. This is -39.7% lower than average price of previous purchases of ARCT. |
| ALLO - Allogene Therapeutics Inc | BUY | 377 @ USD 1.11 | USD 418 | The ETF bought 377 new shares of ALLO (Allogene Therapeutics Inc). The shares were bought for an average price of 1.11 compared to the previous average buy price of 1.33808. This is -17.0% lower than average price of previous purchases of ALLO. |
| HUMA - Humacyte Inc | BUY | 280 @ USD 1.46 | USD 409 | The ETF bought 280 new shares of HUMA (Humacyte Inc). The shares were bought for an average price of 1.46 compared to the previous average buy price of 2.2409. This is -34.8% lower than average price of previous purchases of HUMA. |
| VYGR - Voyager Therapeutics Inc | BUY | 89 @ USD 4.16 | USD 370 | The ETF bought 89 new shares of VYGR (Voyager Therapeutics Inc). The shares were bought for an average price of 4.16 compared to the previous average buy price of 3.83071. This is 8.6% higher than average price of previous purchases of VYGR. |
| OABI - OmniAb Inc. | BUY | 213 @ USD 1.48 | USD 315 | The ETF bought 213 new shares of OABI (OmniAb Inc.). The shares were bought for an average price of 1.48 compared to the previous average buy price of 1.9323. This is -23.4% lower than average price of previous purchases of OABI. |
| MXCT - MaxCyte Inc | BUY | 184 @ USD 1.61 | USD 296 | The ETF bought 184 new shares of MXCT (MaxCyte Inc). The shares were bought for an average price of 1.61 compared to the previous average buy price of 2.20519. This is -27.0% lower than average price of previous purchases of MXCT. |
| ALEC - Alector Inc | BUY | 183 @ USD 1.32 | USD 242 | The ETF bought 183 new shares of ALEC (Alector Inc). The shares were bought for an average price of 1.32 compared to the previous average buy price of 1.95226. This is -32.4% lower than average price of previous purchases of ALEC. |
| FATE - Fate Therapeutics Inc | BUY | 187 @ USD 1.19001 | USD 223 | The ETF bought 187 new shares of FATE (Fate Therapeutics Inc). The shares were bought for an average price of 1.19001 compared to the previous average buy price of 1.19222. This is -0.2% lower than average price of previous purchases of FATE. |
| PLRX - Pliant Therapeutics Inc | BUY | 100 @ USD 1.60999 | USD 161 | The ETF bought 100 new shares of PLRX (Pliant Therapeutics Inc). The shares were bought for an average price of 1.60999 compared to the previous average buy price of 1.48983. This is 8.1% higher than average price of previous purchases of PLRX. |
| MGNX - MacroGenics Inc | BUY | 107 @ USD 1.45001 | USD 155 | The ETF bought 107 new shares of MGNX (MacroGenics Inc). The shares were bought for an average price of 1.45001 compared to the previous average buy price of 1.58218. This is -8.4% lower than average price of previous purchases of MGNX. |
| BMEA - Biomea Fusion Inc | BUY | 119 @ USD 1.26001 | USD 150 | The ETF bought 119 new shares of BMEA (Biomea Fusion Inc). The shares were bought for an average price of 1.26001 compared to the previous average buy price of 1.83183. This is -31.2% lower than average price of previous purchases of BMEA. |
| STRO - Sutro Biopharma | BUY | 136 @ USD 1.01999 | USD 139 | The ETF bought 136 new shares of STRO (Sutro Biopharma). The shares were bought for an average price of 1.01999 compared to the previous average buy price of 0.90011. This is 13.3% higher than average price of previous purchases of STRO. |
| MRSN - Mersana Therapeutics Inc | BUY | 8 @ USD 8.16015 | USD 65 | The ETF bought 8 new shares of MRSN (Mersana Therapeutics Inc). The shares were bought for an average price of 8.16015 compared to the previous average buy price of 0.52291. This is 1,460.5% higher than average price of previous purchases of MRSN. |
| OKUR - OKUR | BUY | 21 @ USD 3.10006 | USD 65 | The ETF bought 21 new shares of OKUR (OKUR). The shares were bought for an average price of 3.10006 compared to the previous average buy price of 6.13912. This is -49.5% lower than average price of previous purchases of OKUR. |
| - - | HOLD | 0 @ USD 0 | USD 0 | |
| CSTL - Castle Biosciences Inc | HOLD | 0 @ USD 31.63 | USD 0 | The current share valuation price of CSTL based on adjusted close was USD 31.63. The average price that CSTL shares were previous bought at was USD 21.1566. The current market price is 49.5% higher than average price they were purchased at. The value of the holding in CSTL has increased by USD 104,599 compared to the previous valuation of Castle Biosciences Inc however if the holding was sold on 2025-11-04 this would crystalise an overall loss. |
| SRPT - Sarepta Therapeutics Inc | HOLD | 0 @ USD 16.2 | USD 0 | The current share valuation price of SRPT based on adjusted close was USD 16.2. The average price that SRPT shares were previous bought at was USD 34.5337. The current market price is -53.1% lower than average price they were purchased at. The value of the holding in SRPT has fallen by USD 513,241 compared to the previous valuation of Sarepta Therapeutics Inc |
| TERN - Tern Plc | HOLD | 0 @ USD 17.43 | USD 0 | The current share valuation price of TERN based on adjusted close was USD 17.43. The average price that TERN shares were previous bought at was USD 5.12922. The current market price is 239.8% higher than average price they were purchased at. The value of the holding in TERN has increased by USD 189,784 compared to the previous valuation of Tern Plc however if the holding was sold on 2025-11-04 this would crystalise an overall loss. |
| THRD - Third Harmonic Bio Inc. | HOLD | 0 @ USD 0.0300173 | USD 0 | The current share valuation price of THRD based on adjusted close was USD 0.0300173. The average price that THRD shares were previous bought at was USD 5.06885. The current market price is -99.4% lower than average price they were purchased at. USD 0 compared to the previous valuation of Third Harmonic Bio Inc. however if the holding was sold on 2025-11-04 this would crystalise an overall loss. |